Enquiry/Quote
Lenalidomide Capsule bulk supplier for pharma manufacturers

Lenalidomide Capsule Suppliers & Bulk Manufacturers

Available Forms: Oral Capsules

Available Strengths: 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg

Reference Brands: Revlimid® (EU & US)

Category: Oncology Cancer Care

Lenalidomide (brand name Revlimid®) is an immunomodulatory drug used to treat multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available in oral capsules with strengths ranging from 2.5 mg to 25 mg, it enhances the immune system and inhibits tumor growth. Sourced by B2B pharmaceutical wholesalers in the US and EU, Lenalidomide ensures a reliable supply of GMP-compliant medications, offering competitive pricing for oncology centers and cancer treatments. Lenalidomide Capsule is available in Oral Capsules and strengths such as 2.5 mg, 5 mg, 10 mg, 15 mg, 25 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lenalidomide Capsule is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lenalidomide Capsule can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Lenalidomide is an immunomodulatory drug (IMiD) used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). Available under the brand Revlimid® by Bristol Myers Squibb, it is offered in oral capsule form in strengths ranging from 2.5 mg to 25 mg. Lenalidomide works by enhancing the immune system and inhibiting tumor cell growth. Widely sourced by B2B pharmaceutical wholesalers in the US and EU, it ensures reliable supply of high-quality, GMP-compliant medications for oncology centers, providing competitive pricing for cancer treatments.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Lenalidomide is used in the treatment of certain hematological cancers, primarily multiple myeloma. It is also indicated for myelodysplastic syndromes (MDS) associated with deletion 5q, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma, either alone or in combination with other anticancer agents, depending on the indication and treatment protocol.

Lenalidomide is a synthetic immunomodulatory agent derived from thalidomide. It is chemically manufactured and designed to enhance immune function, inhibit tumor cell proliferation, and suppress angiogenesis.

Lenalidomide is globally marketed under the trade name Revlimid.

The original branded product Revlimid was developed and marketed by Celgene Corporation, which is now a part of Bristol Myers Squibb. Generic versions are manufactured by several approved pharmaceutical companies in different regions.

The complete generic name is lenalidomide.

The brand name of lenalidomide is Revlimid, along with various approved generic brands available in different countries.

Lenalidomide is manufactured in multiple countries including the United States, European Union countries, India, and other regulated pharmaceutical manufacturing regions, depending on the brand and manufacturer.

Yes, Lenalidomide Capsule is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lenalidomide Capsule is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Capivasertib

Strength:
160 mg

Form: Tablets

Reference Brands: Truqap (USA)

View Details
Toremifene Citrate

Strength:
60 mg

Form: Tablets

Reference Brands: Fareston(USA)

View Details
Ivosidenib

Strength:
250 mg

Form: Tablets

Reference Brands: Tibsovo (USA/EU)

View Details
Thioguanine

Strength:
20 mg, 25 mg, 40 mg

Form: Tablets

Reference Brands: Tabloid (USA), Lanvis (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.